CTI BioPharma Corp. CTIC
9.10 0.00 0.00%
As of Jun 23, 3:58 PM ET
52-week range unavailable
- Open
- 9.10
- Prev close
- 9.10
- Mkt cap
- 1.20B
- Vol
- 5.56M
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 9.09
- High
- 9.10
- Forward P/E
- 101.00
- Beta
- 0.83
- Short ratio
- 1.08
- Inst. own
- 83.29%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 14, 2023
- 50-d avg
- 7.63
- 200-d avg
- 5.87
- 1y target
- 10.37
MAX chart
Chart tools
Chart is warming up
The all-time price history for CTIC has not been loaded yet. Try again in a moment.
Altman Z-Score
-27.02 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
P/E -7.6×
P/S 12.8×
P/B -39.2×
P/FCF -6.5×
EV/EBITDA -9.1×
EV/Sales 13.1×
FCF Yield -15.4%
Gross Margin 93.5%
Operating Margin -147.9%
Net Margin -168.8%
ROE 518.0%
ROIC -84.2%
ROA -72.3%
Revenue 0.0%
Operating Income 16.3%
EPS (diluted) 28.8%
Free Cash Flow -25.1%
Current Ratio 1.2×
Quick Ratio 1.2×
Debt / Equity -2.8×
Net Debt / EBITDA -0.3×
Interest Coverage -6.1×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2022-12-31